PLUXEE N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.9 EUR | -1.86% |
|
-1.18% | 0.00% |
| 04-19 | PLUXEE : Strengthened profitability objectives and earnings adjustments |  |
| 04-19 | CAC40: L'Oréal's share price helps CAC40 close at breakeven | CF |
Valuation
| Fiscal Period: August | 2024 | 2025 | 2026 |
|---|---|---|---|
| Capitalization 1 | 4,513 | - | - |
| Enterprise Value (EV) 1 | 3,435 | 3,417 | 3,082 |
| P/E ratio | 30.3 x | 18.5 x | 15.9 x |
| Yield | 1.09% | 1.38% | 1.58% |
| Capitalization / Revenue | 3.67 x | 3.35 x | 3.05 x |
| EV / Revenue | 2.79 x | 2.53 x | 2.08 x |
| EV / EBITDA | 8.01 x | 7.12 x | 5.73 x |
| EV / FCF | 11.7 x | 9.47 x | 7.65 x |
| FCF Yield | 8.56% | 10.6% | 13.1% |
| Price to Book | 21.8 x | 10.9 x | 6.98 x |
| Nbr of stocks (in thousands) | 146,059 | - | - |
| Reference price 2 | 30.90 | 30.90 | 30.90 |
| Announcement Date | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: August | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net sales 1 | - | 1,231 | 1,348 | 1,478 |
| EBITDA 1 | - | 428.8 | 479.6 | 537.9 |
| EBIT 1 | - | 331.4 | 376.7 | 423.1 |
| Operating Margin | - | 26.93% | 27.94% | 28.62% |
| Earnings before Tax (EBT) 1 | 163 | 242.4 | 358.2 | 409.2 |
| Net income 1 | 81 | 150 | 246.3 | 286.3 |
| Net margin | - | 12.19% | 18.27% | 19.37% |
| EPS 2 | - | 1.021 | 1.671 | 1.945 |
| Free Cash Flow 1 | - | 294 | 360.9 | 402.6 |
| FCF margin | - | 23.9% | 26.77% | 27.24% |
| FCF Conversion (EBITDA) | - | 68.57% | 75.25% | 74.85% |
| FCF Conversion (Net income) | - | 196.07% | 146.52% | 140.64% |
| Dividend per Share 2 | - | 0.3374 | 0.4258 | 0.4896 |
| Announcement Date | 15/09/23 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: August | 2024 S1 | 2024 S2 | 2025 S1 | 2025 S2 |
|---|---|---|---|---|
| Net sales 1 | 593 | 632.6 | 640.7 | 691.1 |
| EBITDA | 201 | - | - | - |
| EBIT 1 | 161 | 177.6 | 176.9 | 199 |
| Operating Margin | 27.15% | 28.08% | 27.62% | 28.8% |
| Earnings before Tax (EBT) | - | - | - | - |
| Net income | - | - | - | - |
| Net margin | - | - | - | - |
| EPS | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 19/04/24 | - | - | - |
1EUR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: August | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net Debt 1 | - | - | - | - |
| Net Cash position 1 | - | 1,078 | 1,097 | 1,432 |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow 1 | - | 294 | 361 | 403 |
| ROE (net income / shareholders' equity) | - | 156% | 81.6% | 54.6% |
| ROA (Net income/ Total Assets) | - | 2.86% | 3.61% | 3.88% |
| Assets 1 | - | 5,236 | 6,827 | 7,383 |
| Book Value Per Share 2 | - | 1.420 | 2.850 | 4.430 |
| Cash Flow per Share 2 | - | 2.150 | 2.680 | 2.980 |
| Capex 1 | - | 144 | 138 | 150 |
| Capex / Sales | - | 11.72% | 10.27% | 10.16% |
| Announcement Date | 15/09/23 | - | - | - |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
30.9
EUR
Average target price
32.64
EUR
Spread / Average Target
+5.63%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 4.91B | |
| +14.85% | 70.23B | |
| +5.12% | 17.08B | |
| +12.12% | 13.77B | |
| +20.33% | 13.57B | |
| +16.67% | 10.15B | |
| -19.27% | 7.04B | |
| -1.15% | 6.18B | |
| +3.30% | 5.27B | |
| +1.07% | 5.06B |
- Stock Market
- Equities
- PLX Stock
- Financials Pluxee N.V.
